Exchange Traded Concepts, LLC Abbott Laboratories Transaction History

Exchange Traded Concepts, LLC

$4.18 Billion
Q3 2024

A detailed history of Exchange Traded Concepts, LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Exchange Traded Concepts, LLC holds 16,975 shares of ABT stock, worth $1.92 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares

16,975

Previous 14,990 13.24%

Holding current value

$1.92 Million

Previous $1.56 Million 24.28%

% of portfolio

0.05%

Previous 0.04%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 10, 2024	BUY	$100.07 - $118.13 $198,638 - $234,488	1,985 Added 13.24%	16,975 $1.94 Million
Q2 2024 Aug 13, 2024	BUY	$100.73 - $112.44 $131,754 - $147,071	1,308 Added 9.56%	14,990 $1.56 Million
Q1 2024 Apr 15, 2024	BUY	$109.52 - $120.96 $486,049 - $536,820	4,438 Added 48.01%	13,682 $1.56 Million
Q4 2023 Jan 05, 2024	SELL	$90.19 - $110.4 $1.98 Million - $2.42 Million	-21,915 Reduced 70.33%	9,244 $1.02 Million
Q3 2023 Oct 18, 2023	BUY	$95.53 - $114.62 $1.77 Million - $2.13 Million	18,546 Added 147.04%	31,159 $3.02 Million
Q2 2023 Jul 20, 2023	SELL	$100.78 - $112.29 $51,901 - $57,829	-515 Reduced 3.92%	12,613 $1.38 Million
Q1 2023 Apr 12, 2023	SELL	$96.86 - $114.01 $7,361 - $8,664	-76 Reduced 0.58%	13,128 $1.33 Million
Q4 2022 Jan 17, 2023	SELL	$95.06 - $111.52 $24,905 - $29,218	-262 Reduced 1.95%	13,204 $1.45 Million
Q3 2022 Oct 07, 2022	SELL	$96.76 - $112.03 $682,641 - $790,371	-7,055 Reduced 34.38%	13,466 $1.3 Million
Q2 2022 Jul 20, 2022	SELL	$102.07 - $123.37 $157,289 - $190,113	-1,541 Reduced 6.98%	20,521 $2.23 Million
Q1 2022 Apr 26, 2022	SELL	$114.02 - $139.04 $4.53 Million - $5.53 Million	-39,740 Reduced 64.3%	22,062 $2.61 Million
Q4 2021 Jan 13, 2022	SELL	$115.53 - $141.46 $406,781 - $498,080	-3,521 Reduced 5.39%	61,802 $8.7 Million
Q3 2021 Oct 18, 2021	BUY	$116.66 - $129.06 $5.33 Million - $5.9 Million	45,708 Added 233.03%	65,323 $7.72 Million
Q2 2021 Jul 30, 2021	BUY	$105.79 - $124.53 $288,595 - $339,717	2,728 Added 16.15%	19,615 $2.27 Million
Q1 2021 Apr 20, 2021	BUY	$108.84 - $128.23 $611,136 - $720,011	5,615 Added 49.81%	16,887 $2.02 Million
Q4 2020 Jan 19, 2021	BUY	$105.0 - $114.42 $735,105 - $801,054	7,001 Added 163.92%	11,272 $1.23 Million
Q3 2020 Oct 30, 2020	BUY	$91.64 - $111.29 $139,384 - $169,272	1,521 Added 55.31%	4,271 $465,000
Q2 2020 Jul 15, 2020	BUY	$76.57 - $98.0 $109,495 - $140,140	1,430 Added 108.33%	2,750 $251,000
Q1 2020 Apr 14, 2020	BUY	$62.82 - $91.86 $35,870 - $52,452	571 Added 76.23%	1,320 $104,000
Q4 2019 Jan 22, 2020	BUY	$78.51 - $87.4 $58,803 - $65,462	749 New	749 $65,000

Others Institutions Holding ABT

# of Institutions

3,161

Shares Held

1.33B

Call Options Held

8.63M

Put Options Held

7.19M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $199B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Exchange Traded Concepts, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Exchange Traded Concepts, LLC with notifications on news.

Account

Exchange Traded Concepts, LLC Abbott Laboratories Transaction History